Page 1

August 16 , 2021 danimer scientific A Biotechnology Company Danimer Scientific , a Next Generation Bioplastics Company , Announces Second Quarter 2021 Results BAINBRIDGE , Ga .-- ( BUSINESS WIRE ) -- Danimer Scientific , Inc. ( NYSE : DNMR ) ( " Danimer " or the " Company " ) , a leading next generation bioplastics company focused on the development and production of biodegradable materials , announced today its financial results for the second quarter ended June 30 , 2021 . Stephen E. Croskrey , Chief Executive Officer of Danimer commented , “ During the second quarter 2021 , we made further inroads in our mission to create consumer packaging and other biodegradable products which address the global plastic waste crisis . Our team completed the Kentucky debottlenecking initiative to improve our production efficiency for Nodax® based resins , and we substantially strengthened our capital resources to further propel our growth . " In August , we closed on the previously announced acquisition of Novomer , Inc. We believe this transaction will accelerate our ability to deliver our proprietary packaging products to leading consumer product clients and is a milestone transaction for Danimer . This transaction is expected to create important efficiencies in our manufacturing of biodegradable polymers . As a result , we expect to continue to build on our industry leading capabilities in application development . Our competitive advantage is our decade long experience blending products that enable next generation biopolymers to perform to the standards required by leading consumer product firms . This acquisition will not only allow us to further strengthen this core competency , but it will also enable us to increase the expected overall volume of finished product we will be able to deliver , all while significantly lowering our production costs and capital expenditure per pound produced . We view this as a big win for Danimer , our shareholders , and our customers . I am excited for the immense opportunities ahead to create a broader range of industry - leading solutions to meet the demand from our growing blue - chip customer base . " Second Quarter 2021 Financial Highlights • Revenues increased 22 % to $ 14.5 million , compared to the second quarter of 2020 , primarily driven by the scale up of PHA production for Phase 1 of the Winchester , Kentucky facility brought on line in 2020. PHA - based products expanded to 29 % of total revenue compared to 7 % in the second quarter of 2020. The Company also benefitted from a $ 1.8 million increase in revenue related to research and development